Is imatinib justified as an adjuvant chemotherapy for patients with recurrent gastrointestinal stromal tumors

I-RUE LAIREY-HENG HUKING-JEN CHANG2022-08-122022-08-1220050172-6390https://www.scopus.com/inward/record.uri?eid=2-s2.0-20644433357&partnerID=40&md5=be162684a74197627e00717388d0303fhttps://scholars.lib.ntu.edu.tw/handle/123456789/616759Is imatinib justified as an adjuvant chemotherapy for patients with recurrent gastrointestinal stromal tumorsjournal article159662132-s2.0-20644433357